Qingfeng Ni

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 02, 2021
MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling.

Zhouyang Cheng, Qingfeng Ni, Lei Qin

|Nov 13, 2019
miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.

Qing-Feng Ni, Yan Zhang, Jia-Wei Yu

Pageof 1